Oncology/Hematology
Leukemia
More in Leukemia
Omidubicel reduced infections in blood cancer patients from 60% to 39% at 100 days posttransplant
Apr 17, 2023
Trial crowns a winner, but how relevant is it amid the changing therapeutic landscape for ALL?
Feb 16, 2023
Reading Room
Continuing Medical Education
1.00 CME Credits